XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. Show more
AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotechΒ (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for...
AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- XBiotech Inc. today announced that it plans to expand itβs campus headquarters with the construction of a new, state-of-the-art research and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.86 | -11.6059379217 | 7.41 | 7.98 | 6.25 | 98886 | 6.95718992 | CS |
4 | 0.05 | 0.769230769231 | 6.5 | 7.98 | 5.62 | 55669 | 6.77264773 | CS |
12 | 0.79 | 13.7152777778 | 5.76 | 7.98 | 5.0201 | 64724 | 6.56415784 | CS |
26 | -0.95 | -12.6666666667 | 7.5 | 9.96 | 4.24 | 85169 | 6.99398304 | CS |
52 | 2.19 | 50.2293577982 | 4.36 | 9.96 | 3.51 | 58183 | 6.56627311 | CS |
156 | -8.11 | -55.3206002729 | 14.66 | 16.47 | 3 | 62295 | 6.82692021 | CS |
260 | -3.49 | -34.7609561753 | 10.04 | 33.2 | 3 | 132713 | 14.4959673 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.